Cerity Partners OCIO’s Bristol-Myers Squibb BMY Stock Holding History

Cerity Partners OCIO’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$2.4M	Buy	33,349 +1,421	+4%	+$107K	0.08%	149
2022 Q3	$2.27M	Buy	31,928 +1,038	+3%	+$75.3K	0.08%	141
2022 Q2	$2.38M	Buy	30,890 +6,233	+25%	+$475K	0.08%	130
2022 Q1	$1.8M	Buy	24,657 +11,480	+87%	+$771K	0.05%	162
2021 Q4	$822K	Buy	13,177 +2,357	+22%	+$138K	0.02%	255
2021 Q3	$640K	Buy	10,820 +1,493	+16%	+$98.3K	0.02%	278
2021 Q2	$623K	Sell	9,327 -3,171	-25%	-$207K	0.02%	276
2021 Q1	$789K	Sell	12,498 -13,972	-53%	-$869K	0.03%	215
2020 Q4	$1.64M	Sell	26,470 -382	-1%	-$23.5K	0.06%	132
2020 Q3	$1.62M	Buy	26,852 +1,164	+5%	+$70.1K	0.07%	121
2020 Q2	$1.51M	Buy	25,688 +190	+0.7%	+$11.4K	0.07%	126
2020 Q1	$1.42M	Sell	25,498 -1,381	-5%	-$84.4K	0.08%	110
2019 Q4	$1.78M	Buy	26,879 +17,089	+175%	+$979K	0.08%	107
2019 Q3	$496K	Buy	9,790 +3,746	+62%	+$176K	0.03%	206
2019 Q2	$274K	Buy	6,044 +1,587	+36%	+$73.9K	0.01%	275
2019 Q1	$213K	Sell	4,457 -393	-8%	-$19.6K	0.01%	280
2018 Q4	$252K	Buy	4,850 +102	+2%	+$5.48K	0.02%	265
2018 Q3	$295K	Sell	4,748 -504	-10%	-$29.9K	0.02%	246
2018 Q2	$291K	Sell	5,252 -164	-3%	-$8.86K	0.02%	229
2018 Q1	$343K	Buy	5,416 +167	+3%	+$10.7K	0.02%	210
2017 Q4	$322K	Sell	5,249 -47	-0.9%	-$2.94K	0.02%	222
2017 Q3	$338K	Buy	5,296 +410	+8%	+$23.9K	0.02%	202
2017 Q2	$272K	Buy	4,886 +442	+10%	+$24.1K	0.02%	220
2017 Q1	$242K	Buy	+4,444	New	+$244K	0.02%	216
2016 Q3	–	Sell	-3,137	Closed	-$229K	–	214
2016 Q2	$229K	Buy	3,137 +2	+0.1%	+$141	0.02%	190
2016 Q1	$200K	Buy	3,135 +2	+0.1%	+$126	0.02%	206
2015 Q4	$216K	Buy	+3,133	New	+$207K	0.02%	198
2015 Q3	–	Sell	-3,128	Closed	-$208K	–	220
2015 Q2	$208K	Sell	3,128 -94	-3%	-$6.2K	0.02%	207
2015 Q1	$208K	Buy	+3,222	New	+$202K	0.02%	204

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Cerity Partners OCIO's BMY Position: Q4 2022 in Review

Cerity Partners OCIO increased its Bristol-Myers Squibb (BMY) stake by 4.5% in Q4 2022, buying an estimated $107K and bringing the position to 33,349 shares worth $2.4M. The position accounts for 0.08% of the portfolio, ranked #149.

Cerity Partners OCIO first reported a position in BMY in Q1 2015 and has held it in 29 quarters since. 2,600 funds tracked by Wall St. Rank hold BMY as of Q4 2022.

Cerity Partners OCIO held 33,349 shares of Bristol-Myers Squibb worth $2.4M as of Q4 2022.
Cerity Partners OCIO bought 1,421 Bristol-Myers Squibb shares in Q4 2022, an estimated $107K.
Bristol-Myers Squibb made up 0.08% of Cerity Partners OCIO's portfolio in Q4 2022, its #149 holding.
Cerity Partners OCIO first reported a position in Bristol-Myers Squibb in Q1 2015 and has held it in 29 quarters since.
2,600 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2022.

Based on Cerity Partners OCIO's 13F filing for Q4 2022, filed 2 Feb 2023.